A use-condition centered approach to authenticated global capabilities: security architectures for large-scale distributed collaboratory environments

por Johnston, W, Larsen, C
Publicado 1997

Regional health workforce monitoring as governance innovation: a German model to coordinate sectoral demand, skill mix and mobility

por Kuhlmann, E., Lauxen, O., Larsen, C.
Publicado 2016

The motivation of breast cancer patients to participate in a national randomized control trial

por Wegge-Larsen, C., Mehlsen, M., Jensen, A. B.
Publicado 2023

Managers attitude towards implementing workplace health promotion programmes to employees in eldercare: a cross-sectional study

por Christensen, J.R., Larsen, C.M., Kolind, M.I.
Publicado 2020

Does a 2-Week Sexual Health in Rehabilitation Course Lead to Sustained Change in Students’ Attitudes?—A Pilot Study

por Gerbild, H., Larsen, C. M., Rolander, B., Areskoug-Josefsson, Kristina
Publicado 2018

Feasibility and efficacy of a novel technology‐based approach to harness social networks for weight loss: the NETworks pilot randomized controlled trial

por Monroe, C. M., Geraci, M., Larsen, C. A., West, D. S.
Publicado 2019

Clinicopathologic Features of Membranous-Like Glomerulopathy With Masked IgG Kappa Deposits

por Larsen, C.P., Boils, C.L., Cossey, L.N., Sharma, S.G., Walker, P.D.
Publicado 2016

Intrauterine growth restriction in piglets modulates postnatal immune function and hepatic transcriptional responses independently of energy intake

por Amdi, C., Larsen, C., Jensen, K. M. R., Tange, E. Ø., Sato, H., Williams, A. R.
Publicado 2023

Real-time digital libraries based on widely distributed, high performance management of large-data-objects

por Johnston, W, Guojun, J, Larsen, C, Lee, J, Hoo, G, Thompson, M, Tierney, B L, Terdiman, J
Publicado 1997

Correlation between human papillomavirus and p16 overexpression in oropharyngeal tumours: a systematic review

por Grønhøj Larsen, C, Gyldenløve, M, Jensen, D H, Therkildsen, M H, Kiss, K, Norrild, B, Konge, L, von Buchwald, C
Publicado 2014

Prognostic value of increase in transcript levels of Tp73 ΔEx2-3 isoforms in low-grade glioma patients

por Wager, M, Guilhot, J, Blanc, J-L, Ferrand, S, Milin, S, Bataille, B, Lapierre, F, Denis, S, Chantereau, T, Larsen, C-J, Karayan-Tapon, L
Publicado 2006

Ten‐year outcomes in a randomized phase II study of kidney transplant recipients administered belatacept 4‐weekly or 8‐weekly

por Vincenti, F., Blancho, G., Durrbach, A., Grannas, G., Grinyó, J., Meier‐Kriesche, H.‐U., Polinsky, M., Yang, L., Larsen, C. P.
Publicado 2017

The status of CDKN2A alpha (p16(INK4A)) and beta (p14(ARF)) transcripts in thyroid tumour progression

por Ferru, A, Fromont, G, Gibelin, H, Guilhot, J, Savagner, F, Tourani, J M, Kraimps, J L, Larsen, C J, Karayan-Tapon, L
Publicado 2006

De novo donor‐specific antibodies in belatacept‐treated vs cyclosporine‐treated kidney‐transplant recipients: Post hoc analyses of the randomized phase III BENEFIT and BENEFIT‐EXT...

por Bray, R. A., Gebel, H. M., Townsend, R., Roberts, M. E., Polinsky, M., Yang, L., Meier‐Kriesche, H.‐U., Larsen, C. P.
Publicado 2018

Posttransplant reduction in preexisting donor‐specific antibody levels after belatacept‐ versus cyclosporine‐based immunosuppression: Post hoc analyses of BENEFIT and BENEFIT‐EXT...

por Bray, R. A., Gebel, H. M., Townsend, R., Roberts, M. E., Polinsky, M., Yang, L., Meier‐Kriesche, H.‐U., Larsen, C. P.
Publicado 2018

Efficacy and Safety Outcomes of Extended Criteria Donor Kidneys by Subtype: Subgroup Analysis of BENEFIT‐EXT at 7 Years After Transplant

por Florman, S., Becker, T., Bresnahan, B., Chevaile‐Ramos, A., Carvalho, D., Grannas, G., Muehlbacher, F., O'Connell, P. J., Meier‐Kriesche, H. U., Larsen, C. P.
Publicado 2016

Prognostic molecular markers with no impact on decision-making: the paradox of gliomas based on a prospective study

por Wager, M, Menei, P, Guilhot, J, Levillain, P, Michalak, S, Bataille, B, Blanc, J-L, Lapierre, F, Rigoard, P, Milin, S, Duthe, F, Bonneau, D, Larsen, C-J, Karayan-Tapon, L
Publicado 2008

ALEFACEPT PROMOTES COSTIMULATION BLOCKADE BASED ALLOGRAFT SURVIVAL IN PRIMATES

por Weaver, T.A., Charafeddine, A.H., Agarwal, A., Turner, A.P., Russell, M., Leopardi, F.V., Kampen, R.L., Stempora, L., Song, M., Larsen, C.P., Kirk, A.D.
Publicado 2009

Gut microbiota composition during a 12-week intervention with delayed-release dimethyl fumarate in multiple sclerosis – a pilot trial

por Storm-Larsen, C, Myhr, K-M, Farbu, E, Midgard, R, Nyquist, K, Broch, L, Berg-Hansen, P, Buness, A, Holm, K, Ueland, T, Fallang, L-E, Burum-Auensen, E, Hov, JR, Holmøy, T
Publicado 2019